+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Studies on the cytochrome P-450 catalyzed ring alpha-carbon oxidation of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)



Studies on the cytochrome P-450 catalyzed ring alpha-carbon oxidation of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)



Chemical Research in Toxicology 3(5): 423-427



In vitro metabolic studies have established that rat liver cytochromes P-450IIB1 and P-450IA1 but not rabbit liver cytochrome P-450IIB4 catalyze the oxidation of the Parkinsonian inducing neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to the corresponding dihydropyridinium (MPDP+) and pyridinium (MPP+) species. Kinetic experiments with the most effective isozyme, cytochrome P-450IA1, indicate that the reaction proceeds at a moderate velocity [Vmax = 20.1 nmol/(min.nmol of P-450IA1)] and high Km (0.87 mM). Furthermore, kinetic deuterium isotope effect measurements provided DV and D(V/K) values of 2.99 and 1.04, respectively. A comparison with the corresponding values for the monoamine oxidase B (MAO-B) catalyzed reaction (4.37 and 9.35, respectively) suggests that either these enzymes catalyze the ring alpha-carbon oxidation of MPTP by different pathways or that the initial one-electron transfer to generate an aminium radical intermediate previously proposed for both enzyme systems is reversible in the case of MAO-B and irreversible in the case of cytochrome P-450IA1.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 041463182

Download citation: RISBibTeXText

PMID: 2133093

DOI: 10.1021/tx00017a006


Related references

Studies on the 1-methyl-4-phenyl-2,3-dihydropyridinium species 2,3-MPDP+, the monoamine oxidase catalyzed oxidation product of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Journal of Medicinal Chemistry 28(10): 1432-1436, 1985

The formation of reactive intermediates in the MAO-catalyzed oxidation of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Toxicology 49(2-3): 513-519, 1988

Studies on the 1-methyl-4-phenyl-2,3-dihydropyridinium species 2,3-Mpdp+, the monoamine oxidase catalyzed oxidation product of the nitrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (Mptp). Journal of Medicinal Chemistry 28(10): 1432-1436, 1985

Mechanism based inhibition of purified monoamine oxidase b by the nigrostriatal toxin mptp 1 methyl 4 phenyl 1 2 3 6 tetrahydropyridine. Federation Proceedings 44(4): 1116, 1985

Metabolic studies on the nigrostriatal toxin 1 methyl 4 phenyl 1 2 3 6 tetrahydropyridine. Sandler, Mahlstrom And R. H. Belmaker (ed.). Neurology And Neurobiology (new York), Vol. 42. Progress In Catecholamine Research, Part B: Central Aspects; Sixth International Catecholamine Symposium, Jerusalem, Israel, June 14-19, . Xxxvi 592p. Alan R. Liss, Inc: New York, New York, Usa. Illus. 93-100, 1988

Studies on semirigid tricyclic analogues of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Journal of Medicinal Chemistry 32(2): 473-477, 1989

Studies on semirigid tricyclic analogs of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Journal of Medicinal Chemistry 32(2): 473-477, 1989

Structure activity study of the mechanism of 1 methyl 4 phenyl 1 2 3 6 tetrahydropyridine mptp induced neurotoxicity ii. evaluation of the biological activity of the pyridinium metabolites formed from the monoamine oxidase catalyzed oxidation of mptp analogs. Journal of Pharmacology and Experimental Therapeutics 249(3): 829-835, 1989

Studies on the molecular mechanism of bioactivation of the selective nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Drug Metabolism and Disposition: the Biological Fate of Chemicals 13(3): 342-347, 1985

Different toxicity of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) on the nigrostriatal and mesolimbic pathways. European Journal of Pharmacology 133(2): 239-241, 1987

Characterization of a product derived from the 1 methyl 4 phenyl 2 3 dihydropyridinium ion a metabolite of the nigrostriatal toxin 1 methyl 4 phenyl 1 2 3 6 tetrahydropyridine. Journal of Organic Chemistry 54(5): 1052-1055, 1989

Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse. Molecular and Chemical Neuropathology 10(3): 171-183, 1989

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) does not destroy nigrostriatal neurons in the scorbutic guinea pig. Life Sciences 36(13): 1233-1238, 1985

Synthesis and toxicity toward nigrostriatal dopamine neurons of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (Mptp) analogs. Journal of Medicinal Chemistry 29(3): 424-427, 1986

N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) affects locomotor activity without producing a nigrostriatal lesion in the rat. Neuroscience Letters 48(2): 179-184, 1984